Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide.
Ferrer RA, Wobus M, List C, Wehner R, Schönefeldt C, Brocard B, Mohr B, Rauner M, Schmitz M, Stiehler M, Ehninger G, Hofbauer LC, Bornhäuser M, Platzbecker U.
Ferrer RA, et al. Among authors: wobus m.
Haematologica. 2013 Nov;98(11):1677-85. doi: 10.3324/haematol.2013.083972. Epub 2013 May 28.
Haematologica. 2013.
PMID: 23716561
Free PMC article.